Literature DB >> 2567295

Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis.

M Ito1, M Tanimoto, H Kamura, M Yoneda, Y Morishima, K Yamauchi, T Itatsu, K Takatsuki, H Saito.   

Abstract

HLA antigen phenotypes and BglII restriction fragment length polymorphism of T cell receptor beta-chain (TCR beta) gene were analyzed in 61 patients with Graves' disease and 50 patients with Hashimoto's thyroiditis. The antigen frequency of HLA-Bw46 in both Graves' disease (23.0%) and Hashimoto's thyroiditis (24.0%) was significantly higher than that in normal population (8.0%), with relative risks (RR) of 3.45 [corrected P (Pc) less than 0.009] and 3.66 (Pc less than 0.02), respectively. Significantly increased frequency of HLA-B51 antigen was also found in Hashimoto's thyroiditis (40.0% vs. 16.3% in controls; RR, 3.42; Pc less than 0.002). Hybridization of BglII-digested DNA with TCR beta probe revealed two alleles of 9.3 and 8.6 kilobases. The allele frequency of 8.6 kilobases in Graves' disease (79%) and Hashimoto's thyroiditis (76%) was significantly higher (P less than 0.01 and P less than 0.05, respectively) than that in controls (64%). The frequency of homozygous state 8.6/8.6 was significantly increased in both Graves' disease (62%) and Hashimoto's thyroiditis (60%) over that in controls (39%); the RR of 8.6/8.6 in Graves' disease and Hashimoto's thyroiditis were 2.55 (P less than 0.01) and 2.31 (P less than 0.05), respectively. These results indicate that in Japanese subjects at least two loci are involved in the susceptibility to Graves' disease and Hashimoto's thyroiditis, one related to HLA and another to TCR beta.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567295     DOI: 10.1210/jcem-69-1-100

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Haplotyping the human T-cell receptor beta-chain gene complex by use of restriction fragment length polymorphisms.

Authors:  P Charmley; A Chao; P Concannon; L Hood; R A Gatti
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Immunogenetic study of thyroid hormone autoantibodies in a family.

Authors:  S Nakamura; M Sugimoto; J Kosaka; T Komaki; H Kamura; T Miyazaki; H Matsumoto; S Sakata
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

3.  A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.

Authors:  M Ito; Y Mori; Y Oiso; H Saito
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

4.  A T cell receptor beta chain variable region polymorphism associated with radiographic progression in rheumatoid arthritis.

Authors:  N de Vries; C F Prinsen; E B Mensink; P L van Riel; M A van't Hof; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

Review 5.  T-cell antigen receptors in rheumatoid arthritis.

Authors:  L I Sakkas; P F Chen; C D Platsoucas
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 6.  Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond.

Authors:  M J Simmonds; S C L Gough
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

7.  Immunogenetics of Hashimoto's thyroiditis.

Authors:  Dimitry A Chistiakov
Journal:  J Autoimmune Dis       Date:  2005-03-11

Review 8.  Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives.

Authors:  Hidefumi Inaba; Toru Aizawa
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-24       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.